{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:02:36Z","timestamp":1759017756698,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.leukres.2023.107070","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T12:56:26Z","timestamp":1680008186000},"page":"107070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Response to chemotherapy in juvenile myelomonocytic leukemia and its clinical implications for survival: A retrospective registry-based study of the Korean Pediatric Hematology-Oncology Group"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8214-2106","authenticated-orcid":false,"given":"Eun Sang","family":"Yi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Jo","family":"Baek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Young","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Koo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0735-0287","authenticated-orcid":false,"given":"Jae Wook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyoung Jin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoon","family":"Kook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eu Jeen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Tak","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Kee","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Min","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Kyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Sun","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5980-7912","authenticated-orcid":false,"given":"Keon Hee","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2023.107070_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00428-022-03447-9","article-title":"The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia","volume":"482","author":"Rudelius","year":"2023","journal-title":"Virchows Arch."},{"key":"10.1016\/j.leukres.2023.107070_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.leukres.2008.08.022","article-title":"Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium","volume":"33","author":"Chan","year":"2009","journal-title":"Leuk. Res"},{"key":"10.1016\/j.leukres.2023.107070_bib3","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1046\/j.1365-2141.2003.04361.x","article-title":"Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population-based study of incidence and survival","volume":"121","author":"Passmore","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2023.107070_bib4","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/s41467-017-02178-9","article-title":"Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia","volume":"8","author":"Stieglitz","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.leukres.2023.107070_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/17474086.2018.1421937","article-title":"Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia","volume":"11","author":"Locatelli","year":"2018","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.leukres.2023.107070_bib6","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2018-11-844688","article-title":"Juvenile myelomonocytic leukemia: who's the driver at the wheel?","volume":"133","author":"Niemeyer","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107070_bib7","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood-2014-08-550483","article-title":"How I treat juvenile myelomonocytic leukemia","volume":"125","author":"Locatelli","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107070_bib8","article-title":"Allogeneic hematopoietic cell transplantation in patients with juvenile myelomonocytic leukemia in Korea: a report of the Korean Pediatric Hematology-Oncology Group","author":"Yi","year":"2022","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.leukres.2023.107070_bib9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/pbc.21038","article-title":"Non-hematopoietic stem cell transplantation treatment of juvenile myelomonocytic leukemia: a retrospective analysis and definition of response criteria","volume":"49","author":"Bergstraesser","year":"2007","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.leukres.2023.107070_bib10","first-page":"434","article-title":"Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the Children's Cancer Group","volume":"20","author":"Woods","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2023.107070_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0145-2126(03)00217-0","article-title":"Novel regimen for the treatment of juvenile myelomonocytic leukemia (JMML","volume":"28","author":"Kang","year":"2004","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2023.107070_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3324\/haematol.2014.109892","article-title":"Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia","volume":"100","author":"Niemeyer","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2023.107070_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1203\/PDR.0b013e3181961d2a","article-title":"Correlation of clinical features with the mutational status of GM-CSF signaling pathway-related genes in juvenile myelomonocytic leukemia","volume":"65","author":"Yoshida","year":"2009","journal-title":"Pedia Res"},{"key":"10.1016\/j.leukres.2023.107070_bib14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/08880018.2020.1767244","article-title":"Outcomes of juvenile myelomonocytic leukemia patients after sequential therapy with cytarabine and 6-mercaptopurine","volume":"37","author":"Wajid","year":"2020","journal-title":"Pedia Hematol. Oncol."},{"key":"10.1016\/j.leukres.2023.107070_bib15","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1182\/bloodadvances.2020004144","article-title":"Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial","volume":"5","author":"Niemeyer","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.leukres.2023.107070_bib16","first-page":"3534","article-title":"Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)","volume":"89","author":"Niemeyer","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107070_bib17","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/leu.2014.58","article-title":"Myeloid progenitors with PTPN11 and nonRAS pathway gene mutations are refractory to treatment with 6-mercaptopurine in juvenile myelomonocytic leukemia","volume":"28","author":"Matsuda","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2023.107070_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fped.2014.00025","article-title":"Juvenile myelomonocytic leukemia: molecular pathogenesis informs current approaches to therapy and hematopoietic cell transplantation","volume":"2","author":"Dvorak","year":"2014","journal-title":"Front Pediatr"},{"key":"10.1016\/j.leukres.2023.107070_bib19","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1182\/blood-2010-08-298968","article-title":"Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome","volume":"117","author":"Olk-Batz","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107070_bib20","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/s41467-017-02177-w","article-title":"RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia","volume":"8","author":"Lipka","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.leukres.2023.107070_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0145-2126(03)00217-0","article-title":"Novel regimen for the treatment of juvenile myelomonocytic leukemia (JMML","volume":"28","author":"Kang","year":"2004","journal-title":"Leuk. Res"},{"key":"10.1016\/j.leukres.2023.107070_bib22","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/16078454.2019.1651548","article-title":"Diagnosis and treatment of juvenile myelomonocytic leukemia","volume":"24","author":"Liao","year":"2019","journal-title":"Hematology"},{"key":"10.1016\/j.leukres.2023.107070_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27034","article-title":"Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study","volume":"65","author":"Dvorak","year":"2018","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.leukres.2023.107070_bib24","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1182\/blood-2013-03-491589","article-title":"Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study","volume":"122","author":"Locatelli","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107070_bib25","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood-2004-05-1944","article-title":"Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS\/EBMT trial","volume":"105","author":"Locatelli","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107070_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27948","article-title":"Molecular assessment of pretransplant chemotherapy in the treatment of juvenile myelomonocytic leukemia","volume":"66","author":"Hecht","year":"2019","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.leukres.2023.107070_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4274\/tjh.2017.0021","article-title":"Juvenile myelomonocytic leukemia in Turkey: a retrospective analysis of sixty-five patients","volume":"35","author":"T\u00fcfek\u00e7i","year":"2018","journal-title":"Turk. J. Haematol."},{"key":"10.1016\/j.leukres.2023.107070_bib28","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/ng.3420","article-title":"Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network","volume":"47","author":"Caye","year":"2015","journal-title":"Nat. Genet"},{"key":"10.1016\/j.leukres.2023.107070_bib29","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/ng.3400","article-title":"The genomic landscape of juvenile myelomonocytic leukemia","volume":"47","author":"Stieglitz","year":"2015","journal-title":"Nat. Genet"},{"key":"10.1016\/j.leukres.2023.107070_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10143084","article-title":"Current treatment of juvenile myelomonocytic leukemia","volume":"10","author":"Mayerhofer","year":"2021","journal-title":"J. Clin. Med"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212623000553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212623000553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:03:45Z","timestamp":1758935025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212623000553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":30,"alternative-id":["S0145212623000553"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2023.107070","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Response to chemotherapy in juvenile myelomonocytic leukemia and its clinical implications for survival: A retrospective registry-based study of the Korean Pediatric Hematology-Oncology Group","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2023.107070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107070"}}